Qiagen NV at Jefferies Global Healthcare Conference in New York Transcript
Okay. We're going to kick it off. I'm Tycho Peterson from the life science team. It's my pleasure to introduce QIAGEN. We've got Roland with us today.
Questions & Answers
Let's jump into it. And maybe setting the stage here, just talking a little bit about trends coming out of 1Q. You had the guidance reset. Just start at a high level, how should we be thinking about what was kind of idiosyncratic in the quarter and broader demand trends as you feel about the rest of the year?
(inaudible) America, so which is probably more important. But I think you're absolutely right. I think overall, the Q1 start of the year was, I would say, a quarter with mixed results. On one side, four of our five growth drivers actually performed quite well. At the same time, QuantiFERON clearly had a difficult start that was due to the immigration
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
